title: Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
authors.affiliation: Department of Pediatric Oncology/Hematology, Princess Noorah Oncology Center, King Abdulaziz Medical City, Jeddah, Kingdom of Saudi Arabia. khattabt@hotmail.com
authors.forename: Taha M
authors.initials: TM
authors.lastname: Khattab
authors.forename: Ayad A
authors.initials: AA
authors.lastname: Atra
authors.forename: Najla A
authors.initials: NA
authors.lastname: Elimam
authors.forename: Ahmed
authors.initials: A
authors.lastname: Kassar
authors.forename: Abdullah
authors.initials: A
authors.lastname: Zayed
authors.forename: Abdullah
authors.initials: A
authors.lastname: Baothman
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012189:Retrospective Studies; D012529:Saudi Arabia / Q000453:epidemiology; D015996:Survival Rate; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D003561:Cytarabine; D005047:Etoposide; D004317:Doxorubicin; D014740:Vidarabine; C024352:fludarabine